Daiichi Sankyo

University of Oxford

vaccines

COVID-19

Japan

Daiichi Sankyo and Thermo Fisher Partner on Companion Diagnostic Device for NSCLC

BioSpace

Tue, 06/23/20 - 11:39 pm

non-small cell lung cancer

Thermo Fisher

companion diagnostics

diagnostics

ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers

Pharmaforum

Sat, 05/30/20 - 08:04 pm

AZ/Daiichi’s Enhertu gains second ‘breakthrough’ tag in space of a week

Pharmaforum

Mon, 05/18/20 - 10:49 am

metastatic non-small-cell lung cancer

Enhertus

AstraZeneca, Daiichi Sankyo get FDA breakthrough therapy status for gastric cancer drug

Pharmaceutical Business Review

Mon, 05/11/20 - 10:27 am

Daiichi Sankyo submits application for CAR T therapy axicabtagene ciloleucel to treat patients with certain relapsed/refractory B-cell lymphomas in Japan

Pharmaceutical Business Review

Tue, 03/31/20 - 11:05 am

relapsed or refractory diffuse large B-cell lymphoma

Japan

CAR-T

axicabtagene ciloleucel

Astra, Daiichi's Enhertu shows early promise in HER2 lung cancer

Fierce Biotech

Wed, 03/25/20 - 10:49 am

HER2-positive non-small cell lung cancer

AZ, Daiichi’s new cancer drug Enhertu gets off to the races with quick U.S. launch

Fierce Pharma

Mon, 02/10/20 - 11:42 pm

Antibody-drug conjugates on the march

Pharmaforum

Thu, 01/30/20 - 10:41 am

Breast cancer approval in tow, AstraZeneca, Daiichi armed antibody scores in key gastric cancer study

Enhertu

Endpoints

Mon, 01/27/20 - 10:44 am

breast cancer

gastric cancer

FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing

Pharmaforum

Mon, 12/23/19 - 11:46 pm

FDA

advanced breast cancer

Enhertu

Daiichi, AstraZeneca breast cancer drug joins bumper crop of early FDA approvals

BioPharma Dive

Fri, 12/20/19 - 08:19 pm

SABCS 2019 – Astrazeneca and Daiichi join the Her2 resistance

EP Vantage

Wed, 12/11/19 - 10:24 am

Seattle Genetics Claims Arbitration Rights in Daiichi Sankyo ADC Dispute

BioSpace

Tue, 12/3/19 - 10:29 pm

Seattle Genetics

Eyeing second Japanese approval, Daiichi and Exelixis announce positive pivotal for kidney drug

Endpoints

Fri, 11/8/19 - 10:40 am

Daiichi Sankyo takes Seattle Genetics to court as battle over breast cancer drug escalates

Pharmaforum

Wed, 11/6/19 - 10:18 am

Herceptin

Daiichi sues Seattle Genetics over tech used in high-profile ADC

Fierce Biotech

Tue, 11/5/19 - 10:34 am

Seattle Genetics

Daiichi Sankyo initiates clinical trial of DS-7300 in collaboration with Sarah Cannon Research Institute

DS-8201

Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot, opioid scrutiny

Fierce Pharma

Mon, 11/4/19 - 07:27 pm

Pharmaceutical Business Review

Fri, 11/1/19 - 10:35 am

Sarah Cannon Research Institute